Wordt geladen...
Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy
Subunit vaccines have been investigated in over 1000 clinical trials of cancer immunotherapy, but have shown limited efficacy. Nanovaccines may improve efficacy but have rarely been clinically translated. By conjugating molecular vaccines with Evans blue (EB) into albumin-binding vaccines (AlbiVax),...
Bewaard in:
Gepubliceerd in: | Nat Commun |
---|---|
Hoofdauteurs: | , , , , , , , , , , , , , , , , , , , , , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Nature Publishing Group UK
2017
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5715147/ https://ncbi.nlm.nih.gov/pubmed/29203865 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-017-02191-y |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|